The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Brzheskiĭ V.V.

GBOU VPO "Sankt-Peterburgskiĭ gosudarstvennyĭ pediatricheskiĭ meditsinskiĭ universitet" Minzdrava Rossii

Golubev S.Yu.

Moscow branch of the Military Medical Academy named after S.M. Kirov, Ministry of Defense of the Russian Federation, 7 Malaya Cherkizovskaya St., Moscow, Russian Federation, 107392

Potential for use of hydroxypropyl guar in tear substitute therapy

Authors:

Brzheskiĭ V.V., Golubev S.Yu.

More about the authors

Journal: Russian Annals of Ophthalmology. 2017;133(1): 88‑96

Read: 3191 times


To cite this article:

Brzheskiĭ VV, Golubev SYu. Potential for use of hydroxypropyl guar in tear substitute therapy. Russian Annals of Ophthalmology. 2017;133(1):88‑96. (In Russ.)
https://doi.org/10.17116/oftalma2017133188-96

Recommended articles:
Diagnostic value of the direct asse­ssment of tear secretion method. Russian Annals of Ophthalmology. 2025;(6):29-34
Meibomian gland dysfunction in Salzmann’s nodu­lar dege­neration. Russian Annals of Ophthalmology. 2025;(6):35-42
Therapeutic pote­ntial of hyaluronic acid and poly­lactic acid for the treatment of atro­phic scars. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):512-522

References:

  1. Safonova TN, Vasil'ev VI, Likhvantseva VG. Sindrom Shegrena: Ruk-vo dlya vrachei. M.: Izd-vo Moskovskogo universiteta, 2013.
  2. McDonald M, Patel DA, Keith MS, Snedecor SJ. Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. Ocular Surface. 2016;14(2):144-167. doi:10.1016/j.jtos.2015.11.002
  3. Brzheskiy VV, Egorova GB, Egorov EA. Sindrom «sukhogo glaza» i zabolevaniya glaznoi poverkhnosti: Klinika, diagnostika, lechenie. M.: GEOTAR-Media, 2016.
  4. Ridder WH, Karsolia A. New drugs for the treatment of dry eye disease. Clin. Optometry. 2015;7:91-102. doi:10.2147/opto.s68271
  5. Abelson MB, Ousler GW III, Nally LA. Dry eye syndromes: diagnosis, clinical trials, and treatment. Cornea. 2000;19(6):S72. doi:10.1097/00003226-200011002-00003
  6. Ablamowicz AF, Nichols JJ. Ocular surface membrane-associated mucins. Ocular Surface.2016;14(3):331-341. doi:10.1016/j.jtos.2016.03.003
  7. Bron AJ, Tomlinson A, Foulks GN et al. Rethinking dry eye disease: A perspective on clinical implications. Ocular Surface. 2014;12(2S):S.1-S.31. doi:10.1016/j.jtos.2014.02.002
  8. Pinto-Fraga J, Abengózar-Vela A, López-Miguel A et al. Effect of the osmolarity change in multipurpose solutions induced by an improper contact lens case cleaning procedure. Cont Lens Ant Eye. 2016;39(3):177-184. doi:10.1016/j.clae.2016.01.011
  9. Lemp MA. Advances in understanding and managing dry eye disease. Amer J Ophthalmol. 2008;146(3):350-356. doi:10.1016/j.ajo.2008.05.016
  10. Akiyama-Fukuda R, Usui T, Yoshida T, Yamagami S. Evaluation of tear meniscus dynamics using anterior segment swept-source optical coherence tomography after topical solution instillation for dry eye. Сornea. 2016;35(5):654-658. doi:10.1097/ico.0000000000000807
  11. Khatib N, Asbell A. Artificial tear substitutes. In: Benitez-del-Castillo JM, Lemp MA. Ocular surface disorders. London etc.: JP Medical Publishers, 2013:235-242.
  12. Christensen MT, Cohen S, Rinehart J et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr. Eye Res. 2004;28(1):55-62. doi:10.1076/ceyr.28.1.55.23495
  13. Yamada M, Mochizuki H Kawai M, et al. Fluorophotometric measurement of pH of human tears in vivo. Curr. Eye Res. 1997;16(5):482-486. doi:10.1076/ceyr.16.5.482.7050
  14. Benelli U. Systane lubricant eye drops in the management of ocular dryness. Clin. Ophthalmol. 2011;5:783-790. doi:10.2147/opth.s13773
  15. Ubels JL, Clousing DP, Van Haitsma TA et al. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent. Curr. Eye Res. 2004;28(6):437-444. doi:10.1080/02713680490503787
  16. Jacobi C, Kruse FE, Cursiefen C. Prospective, randomized, controlled comparison of Systane UD eye drops versus Visine Intensiv 1% EDO eye drops for the treatment of moderate dry eye. J Ocul Pharmacol Ther. 2012;28:598-603. doi:10.1089/jop.2012.0066
  17. Rangarajan R, Kraybill B, Ogundele A, Ketelson HA. Effects of a hyaluronic acid/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497. doi:10.1089/jop.2014.0164
  18. Meyer AE, Baier RE, Chen H, Chowhan M. Tissue on tissue testing of dry eye formulations for reduction of bioadhesion. J. Adhesion. 2006;82:607-627. doi:10.1080/00218460600766673
  19. Kading D. A two-week clinical evaluation of the safety of Systane Ultra in contact lens-wearing patients. Clin Ophthalmol. 2010;4:27-32. doi:10.2147/opth.s8079
  20. Springs C. Novel ocular lubricant containing an intelligent delivery system: Details of its mechanism of action. Dev. Ophthalmol. 2010;45:139-147. doi:10.1159/000315027
  21. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353. doi:10.1089/jop.2010.0025
  22. Torkildsen G. The effects of lubricant eye drops on visual function as measured by the inter-blink interval Visual Acuity Decay test. Clin. Ophthalmol. 2009;3:501-506. doi:10.2147/opth.s6225
  23. Himebaugh NL, Begley CG, Bradley A, Wilkinson JA. Blinking and tear break-up during four visual tasks. Optom. Vis. Sci. 2009;86(2):106-114. doi:10.1097/opx.0b013e318194e962
  24. Rodriguez JD, Lane KJ, Ousler GW et al. Diurnal tracking of blink and relationship to signs and symptoms of dry eye. Cornea. 2016;35(8):1104-1111. doi:10.1097/ico.0000000000000885
  25. Foulks GN, Forstot SL, Donshik PC et al. Clinical guidelines for management of dry eye associated with sjögren disease. Ocular Surface. 2015;13(2):118-132. doi:10.1016/j.jtos.2014.12.001
  26. Sindt CW, Foulks GN. Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction. Clin Ophthalmol. 2013;7:1713-1722. doi:10.2147/opth.s35833
  27. Ketelson HA, Davis J, Meadows D. Characterization of an anionic lipid stabilized ocular emulsion containing HP-guar. Invest Ophthalmol Vis Sci. 2010;43:Abstr.D892.
  28. Pelton R, Hu Z, Ketelson HA Meadows D. Reversible flocculation with hydroxypropyl guar-borate, a labile anionic polyelectrolyte. Langmuir. 2009;25(1):192-195. doi:10.1021/la803095q
  29. Korb DR, Blackie CA, Meadows D et al. Evaluation of extended tear stability by two emulsion based artificial tears. 6th International Conference on the tear film and ocular surface: Basic science and clinical relevance tear film and ocular surface society meeting: Abstract Book. Florence, 2010:83.
  30. Julia Dieckow 6th International conference on the tear film, ocular surface: basic science and clinical relevance (Florence, Italy, September 2010): Highlights from the Platform Sessions. Ocular Surface. 2011;9(1):3-12. doi:10.1016/s1542-0124(11)70004-0
  31. Foulks G, Sindt C, Griffin J. Efficacy evaluation of a novel emulsion based, anionic phospholipid containing artificial tear in meibomian gland dysfunction (MGD) subjects. 6th International Conference on the tear film and ocular surface: Basic science and clinical relevance tear film and ocular surface society meeting: Abstract Book. Florence, 2010:64.
  32. Macri A, Scanarotti Ch, Bassi AM et al. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15% and vitamin B12 eye drops. Graefes Arch Clin Exp Ophthalmol. 2015;253(3):425-430. doi:10.1007/s00417-014-2853-6
  33. Müller-Lierheim WGK. Tränenersatzlösungen. Neues über Hyaluronsäure. Akt Kontaktol. 2015;11(24):17-19.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.